Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, Sang W, Qi K, Li Z, Sun C, Shi M, Qiao J, Wu Q, Zeng L, Zheng J, Xu K, Cao J. Cheng H, et al. Among authors: zeng l. Cytotherapy. 2024 Mar 29:S1465-3249(24)00572-3. doi: 10.1016/j.jcyt.2024.03.481. Online ahead of print. Cytotherapy. 2024. PMID: 38625072
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myeloma.
Li H, Zhao L, Sun Z, Yao Y, Li L, Wang J, Hua T, Ji S, Wang S, Cheng H, Shi M, Li Z, Zeng L, Wu Q, Qiao J, Chen C, Zheng J, Cao J, Xu K. Li H, et al. Among authors: zeng l. Front Immunol. 2022 Oct 18;13:1019548. doi: 10.3389/fimmu.2022.1019548. eCollection 2022. Front Immunol. 2022. PMID: 36330523 Free PMC article. Clinical Trial.
8,204 results